The Harvard Drug Group is recalling 841 cartons of Aripiprazole Tablets USP (15 mg), a prescription medication used to treat certain mental and mood disorders. The recall was initiated because the tablets failed dissolution testing, meaning they were out of specification and may not dissolve properly in the body. These tablets were manufactured by Apotex, Inc. and distributed under the Major Pharmaceuticals brand in unit dose cartons containing 30 tablets each. Consumers should contact their healthcare provider to discuss concerns about their medication and can return any unused product to their pharmacy for a refund.
When a drug fails dissolution specifications, the medication may not be absorbed by the body as intended. This can lead to a lower amount of the active drug in the patient's system, potentially making the treatment less effective or causing a recurrence of symptoms.
Medical consultation and product refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.